The global anatomic pathology market size was valued at USD 24.4 billion by the year 2019. It is projected to grow at a CAGR of 5.4% during the forecast period.
However COVID-19 has affected all the businesses across the globe. It has negatively impacted all the diagnostic industry along with anatomic pathology. Patients visiting hospitals has been reduced in few last months, despite availability of all the services such as OPD and emergency. After commencing any surgeries such as cancer or any other, surgeons run through a set of pathology tests to decide the best treatment for patients but due to lockdown the cancer and elective surgeries has been reduced worldwide. World economic forum has revealed that 38% of cancer surgeries have been postponed due to this pandemic situation.
For more details, visit: Global Anatomic Pathology Market By Products & Services (Services, Instruments, others), By Application (Disease Diagnosis, Medical Research), By End User (Hospitals, Laboratories, others), By Region–Forecast & Opportunities to 2026
However, the lockdown has been lifted in many parts of globe because of which many hospitals have reopened the normal working. Many hospitals across the globe have resumed the elective and cancer surgeries, leading to foresee some growth in this sector. The anatomy pathology in the year 2020 will see some declined but will definitely witness growth in the latter half of forecast period.
Cancer is a very complex disease to diagnose. It develops in multi-stage carcinogenesis process which involves multiple pathways. There are many hurdles associated with the diagnosis of cancer. The treatment of cancer requires anatomic pathology which drives the market to foresee growth during forecast period.
On the basis of product the anatomic pathology market is segmented into services, consumable and instruments. The services segment accounted for maximum market share in 2019. This segment is projected to register growth at highest CAGR during the forecast period. The availability of reimbursement for diagnostic test has driven the market. The rapid growth in population along with rise in cancer and chronic disease cases has attributed growth of this segment during the forecast period.
Based on application the anatomic pathology market has been segmented into disease diagnosis and medical research. The disease diagnosis segment has accounted for maximum market share in 2019. It is estimated to register growth at highest CAGR during the forecast period. The chronic disease cases has been increasing rapidly worldwide thus, driving the diseases diagnosis segment to grow.
On the basis of end-user the market is segmented into hospitals, research laboratories and diagnostic laboratories. The hospital segment has accounted for maximum market share in 2018. The rapid increase in hospitalization rate of cancer patient across the world has driven the hospital segment.
North America accounted for maximum market share in year 2019. It is estimated to maintain its leading position and register growth at highest CAGR during the forecast period. The advanced technologies are easily accessible in this region. There is favorable reimbursement scenario for anatomic pathology diagnosis test along with some great government initiatives for cancer patients has driven the market in North America region during the forecast period.
The key market players in anatomic pathology industry are Danaher Corporation, Agilent Technologies, Hologic, Becto, Dickinson & Company, F. Hoffmann-La Roche Ltd., PHP Holdings Corp., Sakura Finetek, Merc KGaA, Diapath S.P.A., Bio SB, BioGenex Laboratories, Abott Diagnosis, Thermo Fisher Scientific and Laboratory Corporation of America Holdings.
- What are the expected industry trends over the next three to five years?
- Which of the anatomic pathology application is likely to lead by 2025?
- Which of the end-user segments is expected to have the maximum potential to during the forecast period?
- Which region is going to have the highest smart meters market share by 2025?
- What are different organic and inorganic strategies implemented by companies to gain increased market share?